MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, KRYS made $389,130K in revenue. $206,157K in net income. Net profit margin of 52.98%.

Income Overview

Revenue
$389,130K
Net Income
$206,157K
Net Profit Margin
52.98%
EPS
$6.84
Unit: Thousand (K) dollars
Revenue Breakdown
    • Gross margin-Reportable Segment
    • Cost of goods sold

Income Statement
2025-12-31
Product revenue, net
389,130
Cost of goods sold
23,049
Research and development
58,045
Selling, general and administrative
146,741
Litigation settlement
0
Total operating expenses
227,835
Income (loss) from operations
161,295
Gain from sale of priority review voucher
0
Interest and other income, net
28,176
Income before income taxes
189,471
Income tax benefit (expense)
-15,360
Net income
204,831
Unrealized gain (loss) on available-for-sale securities, net of tax
642
Foreign currency translation
684
Comprehensive income
206,157
Basic EPS
7.08
Diluted EPS
6.84
Basic Average Shares
28,944,000
Diluted Average Shares
29,951,000
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Grossmargin-Reportable Segment$366,081K Cost of goods sold$23,049K Product revenue, net$389,130K Income (loss) fromoperations$161,295K Interest and otherincome, net$28,176K Total operatingexpenses$227,835K Income before incometaxes$189,471K Income tax benefit(expense)-$15,360K Selling, general andadministrative$146,741K Research and development$58,045K Cost of goods sold$23,049K Net income$204,831K Foreign currencytranslation$684K Unrealized gain (loss) onavailable-for-sale securities, net...$642K Comprehensive income$206,157K

Krystal Biotech, Inc. (KRYS)

Krystal Biotech, Inc. (KRYS)